Mon, Dec 29, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Balkan Emerging Frontiers Fund 10.19% YTD, bets on medium-term investing

Wednesday, August 28, 2013

Precy Dumlao, Opalesque Asia for New Managers:

The Balkan Emerging Frontiers (BEF) Fund was up 1.85% in July (+10.19% YTD) and posted better returns than other mutual funds investing in the Western Balkans regions, the firm said as it celebrate its third year anniversary. Indeed, the fund was established in April 2010, and began investing on August 1st of the same year. Total return within 36 months from the start of investing is 73.39%.

Other funds made 20-30% loss in this period, while BEF Fund generated more than 70% of net income for you, the fund manager said in a monthly investor letter. Practically: 100,000 EUR investment in other Western Balkan mutual funds three years ago would now result in holdings of only 70,000 to 80,000 EUR, while same amount invested in BEF Fund results in 170,000 EUR. Those of you holding the investment in BEF Fund in this period, now have at least 110% (1.7/0.8) or even more than 140% (1.7/0.7) higher value of holdings comparing to those holding their investment in other Western Balkan funds for the last three years, it he added.

According to the manager the two reasons for their good returns are found in the active management quality and the medium-term approach to investing.

Scrambling for short-term results and jumping from trend to trend usually ends miserably. The reasons are many - higher transaction costs, typically higher tax liabilities and most importa......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its